Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jouko Isojarvi"'
Autor:
Jacqueline French, Victor Biton, Hina Dave, Kamil Detyniecki, Michael A. Gelfand, Hui Gong, Kore Liow, Terence J. O'Brien, Ahmed Sadek, Bree DiVentura, Brittany Reich, Jouko Isojarvi
Publikováno v:
EpilepsiaREFERENCES.
Alprazolam administered via the Staccato® breath-actuated device is delivered into the deep lung for rapid systemic exposure and is a potential therapy for rapid epileptic seizure termination (REST). We conducted an inpatient study (ENGAGE-E-001 [NC
Autor:
Jeremy D. Slater, Mei Sheng Duh, Brian Gorin, Adam Ziemann, Lynn Huynh, Jouko Isojarvi, Carolyn McMicken, Steve Chung
Publikováno v:
Epilepsy Research. 143:120-129
Objective In the absence of randomized clinical trials (RCTs) assessing the relative efficacy of antiepileptic drugs (AEDs), meta-analyses are useful resources for informing treatment choices. This meta-analysis assesses the relative efficacy and tol
Autor:
J. Eric Piña-Garza, Mei Sheng Duh, Jouko Isojarvi, Francis Vekeman, Vivienne Shen, Edward Tuttle, Georgia Montouris, Timothy B. Saurer, Wendy Y. Cheng, Philippe Giguere-Duval
Publikováno v:
Epilepsy & Behavior. 73:46-50
Lennox-Gastaut syndrome (LGS) is a chronic and severe form of epilepsy characterized by intractable seizures, cognitive impairment, and abnormal electroencephalogram findings with slow spike-wave complexes. It typically presents before age 8, but sym
Autor:
Jesus Eric Piña-Garza, Philippe Giguere-Duval, Mei Sheng Duh, Timothy B. Saurer, Joseph Damron, Jouko Isojarvi, Francis Vekeman, Georgia Montouris, Edward Tuttle, Wendy Y. Cheng, Vivienne Shen, Arman Oganisian
Publikováno v:
Current medical research and opinion. 35(8)
Objective: Describe the development of a claims-based classifier utilizing machine learning to identify patients with probable Lennox–Gastaut syndrome (LGS) from six state Medicaid programs.Methods...
Autor:
Jouko Isojarvi, Robert C. Sergott, Katya Cherny, Robert T. Wechsler, Deborah Lee, Kenneth D. Laxer, JoAnn Whittle, Ge Feng, Chris A. Johnson
Publikováno v:
Epilepsia. 57:1634-1642
SummaryObjective Evaluate visual-field and retinal-structure changes following adjunctive vigabatrin treatment in vigabatrin-naive adults with refractory complex partial seizures (rCPS). Methods Prospective, longitudinal, single-arm, open-label study
Autor:
Gregory L. Krauss, Deborah Lee, Yekaterina Dribinsky, W. Donald Shields, Rod Foroozan, Feisal Othman, John M. Pellock, Robert C. Sergott, Edward Faught, Adam Ziemann, Sarah Torri, Jouko Isojarvi
Publikováno v:
Epilepsy & Behavior. 56:15-19
Vigabatrin (Sabril®), approved in the US in 2009, is currently indicated as adjunctive therapy for refractory complex partial seizures (rCPS) in patients ≥ 10 years old who have responded inadequately to several alternative treatments and as monot
Autor:
David Hebert, Antonio Gil-Nagel, Pamela Doty, Victor Biton, Jouko Isojarvi, Nathan B. Fountain
Publikováno v:
Epilepsy & Behavior. 52:119-127
Objective The objective of this study was to describe a priori protocol-defined analyses to evaluate the safety and tolerability of adjunctive oral lacosamide (200–600 mg/day) in adults (ages 16–70 years) with partial-onset seizures (POS) using d
Publikováno v:
Pediatric Neurology. 53:338-342
Background Lennox–Gastaut syndrome is an intractable epileptic encephalopathy marked by frequent drop seizures. Most patients develop moderate intellectual disability and behavioral problems, including hyperactivity, aggressiveness, insecurity, and
Publikováno v:
Journal of Neurology Research. 5:252-256
Autor:
William, Rosenfeld, Nathan B, Fountain, Gintaras, Kaubrys, Elinor, Ben-Menachem, Cindy, McShea, Jouko, Isojarvi, Pamela, Doty, Azita, Tofighy
Publikováno v:
Epilepsy & Behavior. 41:164-170
Long-term (up to 8 years of exposure) safety and efficacy of the antiepileptic drug lacosamide was evaluated in this open-label extension trial (SP615 [ClinicalTrials.gov identifier: NCT00552305]). Patients were enrolled following participation in a